Changchun BCHT Biotechnology Co.

SHSE:688276 Stock Report

Market Cap: CN¥17.0b

Changchun BCHT Biotechnology Past Earnings Performance

Past criteria checks 4/6

Changchun BCHT Biotechnology has been growing earnings at an average annual rate of 4.5%, while the Biotechs industry saw earnings growing at 5.2% annually. Revenues have been growing at an average rate of 4.6% per year. Changchun BCHT Biotechnology's return on equity is 12.5%, and it has net margins of 27.5%.

Key information

4.5%

Earnings growth rate

0.9%

EPS growth rate

Biotechs Industry Growth11.3%
Revenue growth rate4.6%
Return on equity12.5%
Net Margin27.5%
Next Earnings Update20 Apr 2024

Recent past performance updates

We Think That There Are Issues Underlying Changchun BCHT Biotechnology's (SHSE:688276) Earnings

Mar 30
We Think That There Are Issues Underlying Changchun BCHT Biotechnology's (SHSE:688276) Earnings

Recent updates

Changchun BCHT Biotechnology Co. (SHSE:688276) Shares Slammed 25% But Getting In Cheap Might Be Difficult Regardless

Apr 16
Changchun BCHT Biotechnology Co. (SHSE:688276) Shares Slammed 25% But Getting In Cheap Might Be Difficult Regardless

We Think That There Are Issues Underlying Changchun BCHT Biotechnology's (SHSE:688276) Earnings

Mar 30
We Think That There Are Issues Underlying Changchun BCHT Biotechnology's (SHSE:688276) Earnings

Revenue & Expenses Breakdown
Beta

How Changchun BCHT Biotechnology makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

SHSE:688276 Revenue, expenses and earnings (CNY Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
31 Dec 231,825501861198
30 Sep 231,449301733171
30 Jun 231,190219640144
31 Mar 231,113183611139
31 Dec 221,071182586134
30 Sep 221,123222563137
30 Jun 221,061179538159
31 Mar 221,093205522167
31 Dec 211,202244567157
30 Sep 211,304309640141
30 Jun 211,424377681123
31 Mar 211,48942471892
31 Dec 201,44141868993
31 Dec 1997622151865
31 Dec 181,01912867662

Quality Earnings: 688276 has a high level of non-cash earnings.

Growing Profit Margin: 688276's current net profit margins (27.5%) are higher than last year (16.9%).


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: 688276's earnings have grown by 4.5% per year over the past 5 years.

Accelerating Growth: 688276's earnings growth over the past year (176%) exceeds its 5-year average (4.5% per year).

Earnings vs Industry: 688276 earnings growth over the past year (176%) exceeded the Biotechs industry -6.1%.


Return on Equity

High ROE: 688276's Return on Equity (12.5%) is considered low.


Return on Assets


Return on Capital Employed


Discover strong past performing companies

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.